PRESS-RELEASE ·Filed Oct 22, 2026
Press release · Earnings
Price Chart
Loading chart...
Executive Summary
Krystal Biotech, Inc. announced it will report its Q3 2026 results on November 2, 2026.
Key Facts
- Krystal Biotech, Inc. announced it will report its Q3 2026 results on November 2, 2026.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3386262 |
15 reports for KRYS
100% Hit rate @ T+20 Went positive at some point 3 of 4 best @ T+60▲ +26.60%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | Institutional Cluster | $311.52 | awaiting T+20 | — | $320.58 (+2.91%) |
Oct 27, 2026 today | SC 13G/A | $311.52 | awaiting T+20 | — | $320.58 (+2.91%) |
Oct 22, 2026 5d ago | Press Release | $320.13 | awaiting T+20 | — | $320.58 (+0.14%) |
Oct 21, 2026 6d ago | Institutional Cluster | $320.13 | awaiting T+20 | — | $320.58 (+0.14%) |
Oct 15, 2026 12d ago | 8-K | $330.00 | awaiting T+20 | — | $320.58 (−2.85%) |
Sep 4, 2026 7w ago | Insider Cluster | $351.26 $326.81 | ▲ +6.96% | ▲ +8.67% | $320.58 (+8.73%) |
Aug 14, 2026 10w ago | 144 | $335.73 $336.68 | ▲ +0.28% | ▲ +2.26% | $320.58 (−4.51%) |
Aug 3, 2026 12w ago | 8-K | $312.57 $359.36 | ▲ +14.97% | ▲ +13.73% | $320.58 (+2.56%) |
Jul 23, 2026 13w ago | Press Release | $335.19 $346.58 | ▲ +3.40% | ▼ −0.23% | $320.58 (−4.36%) |
Jun 5, 2026 20w ago | Insider Cluster | $301.76 $374.68 | ▲ +24.16% | ▲ +22.53% | $320.58 (+6.24%) |
Showing 10 of 15
US Market Status
Market Closed — Opens in 8h 22m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers